Catalys Pacific Fund, LP
SEC CIK 1746274 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | 10% | 7.90M | — | $43.35M | 1 | 2025-11-20 | 2025-11-20 |
Most active insiders at MLYS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Catalys Pacific Fund, LP | 10% | — | $43.35M |
| 2 | Congleton Jon | CEO, Dir | — | $14.91M |
| 3 | Rodman David Malcom | Chief Medical Off | — | $14.41M |
| 4 | Shah Rajeev M. | Dir | $8.76M | — |
| 5 | Levy Adam Scott | CFO, Sec | — | $6.16M |
| 6 | Warren Eric | Chief Commercial Off | — | $3.30M |
| 7 | Slingsby Brian Taylor | Dir, 10% | — | $3.01M |
| 8 | Gold Alexander M | Dir | — | $1.58M |
| 9 | Karydas Daphne | Dir | — | $925.6K |
| 10 | DiRocco Derek | Dir | — | — |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-11-21 | 2025-11-20 | MLYS | Mineralys Therapeutics, Inc. | Catalys Pacific Fund, LP | 10% | S - Sale | $43.35 | -1.00M | 7.90M | -11% | -$43.35M |
Purchase Sale Sale after option exercise All abbreviations